Author

J. Mock

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:cancer & tumor microenvironment· 2 Organism:mouse· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

D. Neri· 2 shared A. Bera· 1 shared A. Elsayed· 1 shared A. Galbiati· 1 shared A. Shah· 1 shared A. Zana· 1 shared C. Machamer· 1 shared F. D'Alessio· 1 shared

Activity by Year

2020-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPharmacology & Toxicology

D. Neri

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

A novel dimeric FAP-targeting small molecule-radio conjugate with high and prolonged tumour uptake

A. Galbiati, A. Zana, M. Bocci, J. Millul, A. Elsayed, J. Mock, D. Neri, S. Cazzamalli

This paper develops a dimeric FAP-targeting radioligand with prolonged tumour uptake and improved tumour-to-organ ratio, showing potent anti-tumour efficacy in preclinical models.

bioRxiv · Feb 21, 2022Pharmacology & Toxicology

MK2 Expression Promotes Non-Small Cell Lung Cancer Cell Death and Predicts Survival

O. Del Rosario, K. Suresh, M. Kallem, G. Singh, A. Shah, Y. Xin, N. Philip, F. D'Alessio, M. Srivastava, A. Bera, L. Shimoda, M. Merchant, M. Rane, C. Machamer, J. Mock, , M. Damarla

This study shows MK2 promotes apoptosis in non-small cell lung cancer by facilitating caspase 3 nuclear translocation, and higher MK2 expression correlates with better patient survival.

bioRxiv · Nov 30, 2021 · PreprintCancer Biology

Antibody-mediated delivery of LIGHT to the tumor boosts Natural Killer cells and delays tumor progression

M. Stringhini, J. Mock, V. Fontana, P. Murer, D. Neri

This paper develops a LIGHT-based fusion protein that accumulates in tumors and enhances Natural Killer cell activity, slowing tumor growth in mouse models.

bioRxiv · May 8, 2020Immunology